Scalper1 News
Alexion Pharmaceuticals (ALXN) stock got another price target hike but took a breather on Tuesday, a day after the Cheshire, Conn.-based drug company raised its 2014 sales and profit guidance. Alexion stock was down more than 1%, near 177, in afternoon trading on the stock market today. On Monday, the stock rose 7% on its new guidance and a reimbursement deal with France. Alexion said Monday it had concluded discussions with the French government Scalper1 News
Scalper1 News